Lv1
10 积分 2025-01-13 加入
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
1天前
已完结
Development and validation of the Chinese version of the Clinician-reported submental fat rating scale
9个月前
已完结
Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans—a Review
10个月前
已完结
New schizophrenia drug could treat Alzheimer’s disease
10个月前
已完结
皖公网安备34019202002308
